Anti-GRIK1/ EAA3/ EEA3 monoclonal antibody

Anti-GRIK1/ EAA3/ EEA3 antibody for FACS & in-vivo assay

Target products collectionGo to GRIK1/GRIK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T73495-Ab-1/ GM-Tg-hg-T73495-Ab-2Anti-Human GRIK1 monoclonal antibodyHuman
GM-Tg-rg-T73495-Ab-1/ GM-Tg-rg-T73495-Ab-2Anti-Rat GRIK1 monoclonal antibodyRat
GM-Tg-mg-T73495-Ab-1/ GM-Tg-mg-T73495-Ab-2Anti-Mouse GRIK1 monoclonal antibodyMouse
GM-Tg-cynog-T73495-Ab-1/ GM-Tg-cynog-T73495-Ab-2Anti-Cynomolgus/ Rhesus macaque GRIK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T73495-Ab-1/ GM-Tg-felg-T73495-Ab-2Anti-Feline GRIK1 monoclonal antibodyFeline
GM-Tg-cang-T73495-Ab-1/ GM-Tg-cang-T73495-Ab-2Anti-Canine GRIK1 monoclonal antibodyCanine
GM-Tg-bovg-T73495-Ab-1/ GM-Tg-bovg-T73495-Ab-2Anti-Bovine GRIK1 monoclonal antibodyBovine
GM-Tg-equg-T73495-Ab-1/ GM-Tg-equg-T73495-Ab-2Anti-Equine GRIK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T73495-Ab-1/ GM-Tg-hg-T73495-Ab-2; GM-Tg-rg-T73495-Ab-1/ GM-Tg-rg-T73495-Ab-2;
GM-Tg-mg-T73495-Ab-1/ GM-Tg-mg-T73495-Ab-2; GM-Tg-cynog-T73495-Ab-1/ GM-Tg-cynog-T73495-Ab-2;
GM-Tg-felg-T73495-Ab-1/ GM-Tg-felg-T73495-Ab-2; GM-Tg-cang-T73495-Ab-1/ GM-Tg-cang-T73495-Ab-2;
GM-Tg-bovg-T73495-Ab-1/ GM-Tg-bovg-T73495-Ab-2; GM-Tg-equg-T73495-Ab-1/ GM-Tg-equg-T73495-Ab-2
Products NameAnti-GRIK1 monoclonal antibody
Formatmab
Target NameGRIK1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-GRIK1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species GRIK1/ EAA3/ EEA3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T73495
    Target NameGRIK1
    Gene ID2897,14805,29559,705699,487719,101097165,533760,100053602
    Gene Symbol and SynonymsA830007B11Rik,D16Ium24,D16Ium24e,EAA3,EEA3,GLR5,GluK1,GluK5,gluR-5,GLUR5,Glurbeta1,GRIK1
    Uniprot AccessionP39086,P22756
    Uniprot Entry NameGRIK1_HUMAN,GRIK1_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000171189
    Target ClassificationN/A

    The target: GRIK1, gene name: GRIK1, also named as EAA3, EEA3, GLR5, GLUR5, GluK1, gluR-5. Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to alter the properties of ion flow. Alternative splicing, resulting in transcript variants encoding different isoforms, has been noted for this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.